CJC-1295 DAC Hilma Biocare

CJC-1295 DAC — also called Modified GRF or simply DAC — is an advanced synthetic growth hormone–releasing hormone (GHRH) analog engineered to raise natural GH output with exceptional stability. Its Drug Affinity Complex (DAC) binds to albumin in the bloodstream, stretching the half-life to an impressive 6–8 days, so GH and IGF-1 stay elevated from a single weekly dose.
| Active substance | CJC-1295 DAC (Modified GRF) |
| Brand | Hilma Biocare |
| Half-life | 6–8 days (albumin binding) |
| Class | GHRH analog / GH secretagogue |
| Typical dose | ~2 mg per week |
| Best for | GH & IGF-1, recovery, recomposition |
How CJC-1295 DAC works
As a GHRH analog, CJC-1295 signals the pituitary to release more of your own growth hormone in a natural, pulsatile way. The DAC technology keeps blood levels steady for days, gently lifting baseline GH and IGF-1 — which supports lean muscle, fat loss, deeper sleep and faster recovery without the sharp spikes of injected HGH.
- Increases natural GH and IGF-1 production
- Supports lean muscle growth and fat loss
- Improves recovery, sleep and skin quality
- Long-acting — convenient weekly dosing
Dosage and use
A common approach is around 2 mg per week, reconstituted with bacteriostatic water and injected subcutaneously. Because it is long-acting, dosing frequency is low. As a GH-focused peptide, it works best run consistently over 8–12 weeks or longer.
Stacking CJC-1295 DAC
For a stronger, more natural GH pulse, CJC-1295 is classically paired with a GHRP such as Ipamorelin or GHRP-2. Together they amplify each other's effect on growth-hormone release.
Why Hilma Biocare
Every vial of CJC-1295 DAC from Hilma Biocare is manufactured to pharmaceutical standards with verified purity, competitively priced and shipped fast and discreetly from our EU warehouse. Order today and lift your GH the smart way.
| Characteristics | |
| Shelf Life | 36 months from manufacture date |
| Drug Class | Growth Hormone Releasing Hormone (GHRH) Analog |
| Concentration | Typically 2 mg per vial |
| Half-Life | Approximately 8 days |
| Detection Time | Not typically tested in standard drug screenings |
| Active Substance | CJC-1295 DAC |
| Dosage | 1-2 mg per week |
| Drug Category | Peptide |
| Form | Lyophilized powder |
| Product Packaging | 2 mg vial |
| Liver Toxicity | None |
| Chemical Structure | Modified peptide with DAC technology |
